T, P., AK, C., DR, M., RN, U., N, S., S, P., . . . S, C. (2018). Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers. Pain medicine (Malden, Mass.), 19(10), 1988. https://doi.org/10.1093/pm/pnx235
Chicago Style (17th ed.) CitationT, Priestley, Chappa AK, Mould DR, Upton RN, Shusterman N, Passik S, Tormo VJ, and Camper S. "Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers." Pain Medicine (Malden, Mass.) 19, no. 10 (2018): 1988. https://doi.org/10.1093/pm/pnx235.
MLA (9th ed.) CitationT, Priestley, et al. "Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers." Pain Medicine (Malden, Mass.), vol. 19, no. 10, 2018, p. 1988, https://doi.org/10.1093/pm/pnx235.